Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, TG Therapeutics, Inc. (TGTX) has a Wall Street consensus price target of $49.50, based on estimates from 13 covering analysts. With the stock currently trading at $30.09, this represents a potential upside of +64.5%. The company has a market capitalization of $4.75B.
Analyst price targets range from a low of $39.00 to a high of $60.00, representing a 42% spread in expectations. The median target of $49.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 11 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, TGTX trades at a trailing P/E of 200.6x and forward P/E of 19.4x. Analysts expect EPS to grow +317.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $30.09, with bear and bull scenarios of $-31912.72 and $6.68 respectively. Model confidence stands at 33/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how TGTX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for TGTX is $49.5, representing 64.5% upside from the current price of $30.09. With 13 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
TGTX has a consensus rating of "Buy" based on 13 Wall Street analysts. The rating breakdown is predominantly bullish, with 11 Buy/Strong Buy ratings. The consensus 12-month price target of $49.5 implies 64.5% upside from current levels.
With a forward P/E of 19.3966x, TGTX trades at a relatively low valuation. The consensus target of $49.5 implies 64.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $60 for TGTX, while the most conservative target is $39. The consensus of $49.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $7 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
TGTX is moderately covered, with 13 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 11 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TGTX stock forecast based on 13 Wall Street analysts shows a consensus price target of $49.5, with estimates ranging from $39 (bear case) to $60 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $30, with bear/bull scenarios of $-31913/$7.
Our quantitative valuation model calculates TGTX's fair value at $30 (base case), with a bear case of $-31913 and bull case of $7. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 33/100.
TGTX trades at a forward P/E ratio of 19.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 200.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on TGTX, with a "Buy" consensus rating and $49.5 price target (64.5% upside). 11 of 13 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TGTX analyst price targets range from $39 to $60, a 42% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $49.5 consensus represents the middle ground. Our model's $-31913-$7 range provides an independent fundamental perspective.